nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—COL8A1—age related macular degeneration	0.0303	0.038	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—COL8A1—age related macular degeneration	0.0303	0.038	CbGpPWpGaD
Boceprevir—CTSV—eye—age related macular degeneration	0.0277	0.137	CbGeAlD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—COL10A1—age related macular degeneration	0.0258	0.0323	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—COL10A1—age related macular degeneration	0.0258	0.0323	CbGpPWpGaD
Boceprevir—CMA1—connective tissue—age related macular degeneration	0.0255	0.126	CbGeAlD
Boceprevir—CTSL—eye—age related macular degeneration	0.0227	0.112	CbGeAlD
Boceprevir—CTSL—retina—age related macular degeneration	0.0224	0.111	CbGeAlD
Boceprevir—CTSL—connective tissue—age related macular degeneration	0.0218	0.108	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—TIMP3—age related macular degeneration	0.0218	0.0274	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—COL10A1—age related macular degeneration	0.0218	0.0274	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL8A1—age related macular degeneration	0.0207	0.0259	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—COL8A1—age related macular degeneration	0.0206	0.0259	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—COL8A1—age related macular degeneration	0.0206	0.0259	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL10A1—age related macular degeneration	0.0176	0.022	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—COL10A1—age related macular degeneration	0.0176	0.022	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—COL10A1—age related macular degeneration	0.0176	0.022	CbGpPWpGaD
Boceprevir—CTSK—eye—age related macular degeneration	0.0171	0.0843	CbGeAlD
Boceprevir—CTSK—retina—age related macular degeneration	0.0169	0.0835	CbGeAlD
Boceprevir—CTSV—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.0168	0.021	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.0168	0.021	CbGpPWpGaD
Boceprevir—CTSK—connective tissue—age related macular degeneration	0.0164	0.0812	CbGeAlD
Boceprevir—CMA1—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.0156	0.0195	CbGpPWpGaD
Boceprevir—CTSS—retina—age related macular degeneration	0.0148	0.0732	CbGeAlD
Boceprevir—CTSS—connective tissue—age related macular degeneration	0.0144	0.0712	CbGeAlD
Boceprevir—CTSS—Collagen formation—COL8A1—age related macular degeneration	0.0141	0.0177	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.0139	0.0174	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—COL10A1—age related macular degeneration	0.012	0.015	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.0114	0.0143	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.00904	0.0113	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00826	0.0104	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00826	0.0104	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00788	0.00988	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00788	0.00988	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00788	0.00988	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00788	0.00988	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00768	0.00963	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00733	0.00919	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00733	0.00919	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00702	0.00881	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00702	0.00881	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00702	0.00881	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00702	0.00881	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00685	0.00858	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00653	0.00819	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00653	0.00819	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00653	0.00819	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00653	0.00819	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00582	0.0073	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00582	0.0073	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00564	0.00707	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—CD36—age related macular degeneration	0.00542	0.00679	CbGpPWpGaD
Boceprevir—CTSL—Antigen processing-Cross presentation—CD36—age related macular degeneration	0.00542	0.00679	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00538	0.00674	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00538	0.00674	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TLR4—age related macular degeneration	0.0051	0.00639	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00479	0.00601	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00479	0.00601	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00474	0.00594	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00474	0.00594	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—C9—age related macular degeneration	0.00466	0.00585	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—C9—age related macular degeneration	0.00466	0.00585	CbGpPWpGaD
Boceprevir—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.00436	0.00547	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CFI—age related macular degeneration	0.00404	0.00507	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CFI—age related macular degeneration	0.00404	0.00507	CbGpPWpGaD
Boceprevir—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.00389	0.00488	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—C9—age related macular degeneration	0.00386	0.00484	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CFHR3—age related macular degeneration	0.00376	0.00471	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CFHR3—age related macular degeneration	0.00376	0.00471	CbGpPWpGaD
Boceprevir—CTSS—Antigen processing-Cross presentation—CD36—age related macular degeneration	0.0037	0.00464	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00344	0.00432	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00344	0.00432	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CFI—age related macular degeneration	0.00335	0.0042	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—C2—age related macular degeneration	0.00335	0.0042	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—C2—age related macular degeneration	0.00335	0.0042	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—C9—age related macular degeneration	0.00318	0.00399	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CFHR3—age related macular degeneration	0.00311	0.0039	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—VEGFA—age related macular degeneration	0.00308	0.00387	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00305	0.00383	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00298	0.00373	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00298	0.00373	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00285	0.00358	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CFH—age related macular degeneration	0.0028	0.00351	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CFH—age related macular degeneration	0.0028	0.00351	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—C2—age related macular degeneration	0.00278	0.00348	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CFI—age related macular degeneration	0.00276	0.00346	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CFB—age related macular degeneration	0.00272	0.00341	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CFB—age related macular degeneration	0.00272	0.00341	CbGpPWpGaD
Boceprevir—CTSV—Immune System—C9—age related macular degeneration	0.00272	0.0034	CbGpPWpGaD
Boceprevir—CTSL—Immune System—C9—age related macular degeneration	0.00272	0.0034	CbGpPWpGaD
Boceprevir—ABCB1—retina—age related macular degeneration	0.00261	0.0129	CbGeAlD
Boceprevir—CTSS—Innate Immune System—CFHR3—age related macular degeneration	0.00256	0.00322	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00247	0.00309	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CFI—age related macular degeneration	0.00235	0.00295	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CFI—age related macular degeneration	0.00235	0.00295	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00235	0.00295	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CFH—age related macular degeneration	0.00232	0.00291	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—C2—age related macular degeneration	0.00229	0.00287	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CFB—age related macular degeneration	0.00225	0.00282	CbGpPWpGaD
Boceprevir—CTSK—Immune System—C9—age related macular degeneration	0.00225	0.00282	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CFHR3—age related macular degeneration	0.00219	0.00274	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CFHR3—age related macular degeneration	0.00219	0.00274	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—CD36—age related macular degeneration	0.00216	0.00271	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—CD36—age related macular degeneration	0.00216	0.00271	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00203	0.00255	CbGpPWpGaD
Boceprevir—CTSV—Immune System—C2—age related macular degeneration	0.00195	0.00245	CbGpPWpGaD
Boceprevir—CTSL—Immune System—C2—age related macular degeneration	0.00195	0.00245	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CFI—age related macular degeneration	0.00195	0.00245	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CFH—age related macular degeneration	0.00191	0.0024	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RDH8—age related macular degeneration	0.00187	0.00234	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CFB—age related macular degeneration	0.00185	0.00232	CbGpPWpGaD
Boceprevir—CTSS—Immune System—C9—age related macular degeneration	0.00185	0.00232	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CFHR3—age related macular degeneration	0.00181	0.00227	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—KDR—age related macular degeneration	0.0018	0.00226	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—KDR—age related macular degeneration	0.0018	0.00226	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—KDR—age related macular degeneration	0.00168	0.0021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RPE65—age related macular degeneration	0.00163	0.00205	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CFH—age related macular degeneration	0.00163	0.00205	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CFH—age related macular degeneration	0.00163	0.00205	CbGpPWpGaD
Boceprevir—CTSK—Immune System—C2—age related macular degeneration	0.00162	0.00203	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CFI—age related macular degeneration	0.00161	0.00201	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CFB—age related macular degeneration	0.00158	0.00198	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CFB—age related macular degeneration	0.00158	0.00198	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CFHR3—age related macular degeneration	0.00149	0.00187	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—KDR—age related macular degeneration	0.00149	0.00187	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—CD36—age related macular degeneration	0.00148	0.00185	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CFH—age related macular degeneration	0.00135	0.0017	CbGpPWpGaD
Boceprevir—CTSS—Immune System—C2—age related macular degeneration	0.00133	0.00167	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ABCA4—age related macular degeneration	0.00132	0.00165	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CFB—age related macular degeneration	0.00131	0.00164	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—KDR—age related macular degeneration	0.00123	0.00154	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RHO—age related macular degeneration	0.00114	0.00144	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD36—age related macular degeneration	0.00112	0.0014	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD36—age related macular degeneration	0.00112	0.0014	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CFH—age related macular degeneration	0.00111	0.0014	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CFB—age related macular degeneration	0.00108	0.00135	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD36—age related macular degeneration	0.00107	0.00134	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD36—age related macular degeneration	0.00107	0.00134	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—C3—age related macular degeneration	0.00106	0.00133	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—C3—age related macular degeneration	0.00106	0.00133	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—C3—age related macular degeneration	0.00101	0.00127	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—C3—age related macular degeneration	0.00101	0.00127	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CRP—age related macular degeneration	0.00101	0.00126	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CRP—age related macular degeneration	0.00101	0.00126	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SQSTM1—age related macular degeneration	0.000969	0.00122	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SQSTM1—age related macular degeneration	0.000969	0.00122	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR4—age related macular degeneration	0.000964	0.00121	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR4—age related macular degeneration	0.000964	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD36—age related macular degeneration	0.000924	0.00116	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD36—age related macular degeneration	0.000888	0.00111	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—C3—age related macular degeneration	0.000876	0.0011	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—C3—age related macular degeneration	0.000841	0.00105	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CRP—age related macular degeneration	0.000833	0.00104	CbGpPWpGaD
Boceprevir—CTSK—Immune System—SQSTM1—age related macular degeneration	0.000803	0.00101	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR4—age related macular degeneration	0.000799	0.001	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD36—age related macular degeneration	0.000761	0.000954	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD36—age related macular degeneration	0.000731	0.000916	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—C3—age related macular degeneration	0.000721	0.000904	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—C3—age related macular degeneration	0.000693	0.000868	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CRP—age related macular degeneration	0.000686	0.00086	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CCL2—age related macular degeneration	0.000672	0.000842	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SQSTM1—age related macular degeneration	0.000661	0.000829	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TLR4—age related macular degeneration	0.000658	0.000825	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD36—age related macular degeneration	0.00065	0.000815	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD36—age related macular degeneration	0.00065	0.000815	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000642	0.000806	CbGpPWpGaD
Boceprevir—CTSV—Immune System—C3—age related macular degeneration	0.000616	0.000772	CbGpPWpGaD
Boceprevir—CTSL—Immune System—C3—age related macular degeneration	0.000616	0.000772	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—age related macular degeneration	0.000586	0.000734	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CRP—age related macular degeneration	0.000586	0.000734	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.000583	0.000731	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000582	0.00073	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR4—age related macular degeneration	0.000561	0.000704	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR4—age related macular degeneration	0.000561	0.000704	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000557	0.000698	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD36—age related macular degeneration	0.000538	0.000675	CbGpPWpGaD
Boceprevir—CTSK—Immune System—C3—age related macular degeneration	0.00051	0.00064	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.0005	0.000627	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CRP—age related macular degeneration	0.000485	0.000609	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TLR4—age related macular degeneration	0.000465	0.000583	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000456	0.000572	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD36—age related macular degeneration	0.000443	0.000556	CbGpPWpGaD
Boceprevir—CTSS—Immune System—C3—age related macular degeneration	0.00042	0.000527	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000406	0.00051	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000406	0.00051	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CRP—age related macular degeneration	0.0004	0.000501	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR4—age related macular degeneration	0.000383	0.00048	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—C3—age related macular degeneration	0.00037	0.000464	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000358	0.000449	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—age related macular degeneration	0.000344	0.000432	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000338	0.000424	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KDR—age related macular degeneration	0.000337	0.000423	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000313	0.000392	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000293	0.000368	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—age related macular degeneration	0.00029	0.000363	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00027	0.000339	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.000252	0.000316	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000236	0.000296	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000201	0.000252	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.00019	0.000239	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—age related macular degeneration	0.000186	0.000233	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000166	0.000209	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000145	0.000182	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000145	0.000181	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000129	0.000162	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000125	0.000156	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000117	0.000147	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LIPC—age related macular degeneration	9.74e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CETP—age related macular degeneration	9.4e-05	0.000118	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD36—age related macular degeneration	7.49e-05	9.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—age related macular degeneration	6.61e-05	8.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LIPC—age related macular degeneration	6e-05	7.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CETP—age related macular degeneration	5.79e-05	7.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD36—age related macular degeneration	5.65e-05	7.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—age related macular degeneration	4.98e-05	6.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD36—age related macular degeneration	3.48e-05	4.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—age related macular degeneration	3.07e-05	3.85e-05	CbGpPWpGaD
